Fulcrum Therapeutics, Inc. (FULC) News
Follow Fulcrum Therapeutics, Inc. (FULC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Fulcrum Therapeutics Agrees to Sell HbF Assets for About $7 Million
Fulcrum Therapeutics agreed to sell its early-stage fetal hemoglobin assets for approximately $7.0 million in cash.
MNA | Nov 12, 2026, 09:13 PM UTC
M
Fulcrum Therapeutics Q3'26 Earnings Preview: EPS Estimate $(0.07)
Fulcrum Therapeutics is scheduled to report Q3'26 results on October 29; the release time is unspecified. EPS is estimated at $(0.07).
EQUITY | Oct 28, 2026, 11:04 AM UTC
M
Fulcrum Therapeutics, Slate Medicines announce merger agreement
Fulcrum Therapeutics and Slate Medicines announce a merger agreement to advance next-generation migraine therapies.
MNA | Aug 17, 2026, 11:00 AM UTC
L
FULC: Block Trade
FULC block trade of 640k shares at $3.60
EQUITY | Jun 18, 2026, 07:02 PM UTC